BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 1979507)

  • 1. Functional evidence for heterogeneity of peripheral prejunctional alpha 2-adrenoceptors.
    Connaughton S; Docherty JR
    Br J Pharmacol; 1990 Oct; 101(2):285-90. PubMed ID: 1979507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations of prejunctional alpha 2-adrenoceptors in rat atrium, vas deferens and submandibular gland.
    Smith K; Connaughton S; Docherty JR
    Eur J Pharmacol; 1992 Feb; 211(2):251-6. PubMed ID: 1351849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are the prejunctional alpha 2-adrenoceptors of the rat vas deferens and submandibular gland of the alpha 2A- or alpha 2D-subtype?
    Smith K; Docherty JR
    Eur J Pharmacol; 1992 Aug; 219(2):203-10. PubMed ID: 1358640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the subtypes of alpha2-adrenoceptor mediating prejunctional inhibition in rat atrium and cerebral cortex.
    Ho SL; Honner V; Docherty JR
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):634-9. PubMed ID: 9686939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for differences between pre- and postjunctional alpha 2-adrenoceptors in the periphery.
    Connaughton S; Docherty JR
    Br J Pharmacol; 1990 Jan; 99(1):97-102. PubMed ID: 1970496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
    Aboud R; Shafii M; Docherty JR
    Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
    Ohmura T; Oshita M; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
    Akers I; Coates J; Drew GM; Sullivan AT
    Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
    Doxey JC; Roach AG; Smith CF
    Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of 8-hydroxy-2-(N-dipropylamino) tetralin (8-OH-DPAT) at alpha 2-adrenoceptors.
    Borton M; Connaughton S; Docherty JR
    J Auton Pharmacol; 1991 Aug; 11(4):247-53. PubMed ID: 1658007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the subtype of alpha 2-adrenoceptor mediating prejunctional inhibition of cardioacceleration in the pithed rat heart.
    Smith K; Gavin K; Docherty JR
    Br J Pharmacol; 1995 May; 115(2):316-20. PubMed ID: 7670733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors.
    Oriowo MA; Hieble JP; Ruffolo RR
    Pharmacology; 1991; 43(1):1-13. PubMed ID: 1683709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-adrenoceptor antagonism by apoyohimbine and some observations on the pharmacology of alpha-adrenoceptors in the rat anococcygeus and vas deferens.
    McGrath JC
    Br J Pharmacol; 1984 Aug; 82(4):769-81. PubMed ID: 6148114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different sites of action for alpha 2-adrenoceptor antagonists in the modulation of noradrenaline release and contraction response in the vas deferens of the rat.
    Harsing LG; Vizi ES
    J Pharm Pharmacol; 1992 Mar; 44(3):231-4. PubMed ID: 1354730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat.
    Eltze M; Boer R
    Eur J Pharmacol; 1992 Dec; 224(2-3):125-36. PubMed ID: 1361446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053.
    Marshall I; Burt RP; Green GM; Hussain MB; Chapple CR
    Br J Pharmacol; 1996 Sep; 119(2):407-15. PubMed ID: 8886428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of potency of alpha 2-adrenoceptor antagonists in vitro: evidence for heterogeneity of alpha 2-adrenoceptors.
    Alabaster VA; Keir RF; Peters CJ
    Br J Pharmacol; 1986 Jul; 88(3):607-14. PubMed ID: 2874857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of neurotransmission in vas deferens from alpha(2A/D)-adrenoceptor knockout mice.
    Cleary L; Vandeputte C; Docherty JR
    Br J Pharmacol; 2002 Jul; 136(6):857-64. PubMed ID: 12110610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of alpha 1-adrenoceptors and functional consequences in the bisected rat vas deferens following chronic inhibition of neuronal noradrenaline uptake.
    Sallés J; Badia A
    Br J Pharmacol; 1993 Mar; 108(3):678-83. PubMed ID: 8096783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
    Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
    Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.